AstraZeneca is committed to providing resources for our patients, their loved ones and the healthcare professionals caring for them during these uncertain times. Click here for our COVID-19 resource page.

US-39264 Last Updated 4/20
Women Image
Women Image

Used along with diet and exercise for adults with type 2 diabetes who are not at goal with metformin

FAQs

Answers to your most frequently asked questions

Whether you're starting on BYDUREON BCise® or you've been taking the medicine for a while, here's a place for you to go for answers to common questions. There are even helpful videos to watch from Kristen, a registered nurse from the BYDUREON BCise support team.

More video answers:

Frequently asked questions

Each category contains the most frequently asked questions about the BYDUREON BCise experience.

Select an option below to see if your question can be answered here.

Can't find the answer you're looking for? Simply call us at 1-844-MY-BCISE (1-844-692-2473). We’re available from 8 AM to 8 PM ET, Monday through Friday and 10 AM to 6 PM, Saturday and Sunday.

BYDUREON BCise may cause serious side effects, including:

 
  • POSSIBLE THYROID TUMORS, INCLUDING CANCER Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In animal studies, BYDUREON and medicines that work like it caused thyroid tumors, including thyroid cancer. It is not known if BYDUREON BCise will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people

 

  • Do not use BYDUREON BCise if you or any of your family members have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

 

  • Do not use BYDUREON BCise if you have had an allergic reaction to exenatide or any of the other ingredients in BYDUREON BCise

 

  • Inflammation of the pancreas (pancreatitis) Stop using BYDUREON BCise and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back

 

  • Low blood sugar (hypoglycemia) Your risk for getting low blood sugar may be higher if you use BYDUREON BCise with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Tell your healthcare provider if you take other diabetes medicines. Talk to your healthcare provider about managing low blood sugar. Signs and symptoms of low blood sugar include dizziness or lightheadedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness, or feeling jittery

 

  • Kidney problems (kidney failure) Tell your healthcare provider if you have or had kidney problems. In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse

 

  • Stomach problems Tell your healthcare provider if you have severe stomach problems, such as slowed emptying of your stomach (gastroparesis) or problems digesting food. Other medicines like BYDUREON BCise may cause severe stomach problems. It is not known if BYDUREON BCise causes or worsens stomach problems

 

  • Serious allergic reactions Stop using BYDUREON BCise and get medical help right away if you have any symptoms of a serious allergic reaction, including itching, rash, or difficulty breathing

 

  • Injection-site reactions Serious injection-site reactions, with or without bumps (nodules), have happened in some people who use BYDUREON BCise. Some of these injection-site reactions have required surgery. Call your healthcare provider if you have any symptoms of injection-site reactions, including severe pain, swelling, blisters, an open wound, or a dark scab
 
 
  • Gallbladder problems have happened in some people who take BYDUREON or other medicines like it. Tell your healthcare provider right away if you get symptoms of gallbladder problems including pain in the right or middle upper stomach area, nausea and vomiting, fever, or your skin or the white part of your eyes turns yellow

 

The most common adverse reactions with BYDUREON BCise include a bump at the injection site and nausea. Other side effects that occur less often include headache, diarrhea, vomiting, injection site itching and redness, dizziness, and constipation.

These are not all the possible side effects of BYDUREON BCise. See the Important Safety Information for more information and talk to your healthcare provider if you have any side effects that bother you or do not go away.
 

Also, talk to your healthcare provider if you have any changes in your medical condition or the medicines you take.
 

For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Nausea is a common side effect of BYDUREON BCise when you first start using it but decreases over time in most people as their body gets used to the medicine. In BYDUREON BCise clinical studies, about 1 in 12 people felt nausea.

Talk to your healthcare provider if you have any side effects that are bothersome or do not go away.

Your risk for getting low blood sugar is higher if you use BYDUREON BCise with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
 

In clinical studies, serious cases of hypoglycemia occurred in approximately 2% of patients taking BYDUREON BCise, mostly in patients also taking a sulfonylurea.
 

Signs and symptoms of low blood sugar may include:
 

  • dizziness or light-headedness
  • sweating
  • confusion or drowsiness
  • headache
  • blurred vision
  • slurred speech
  • shakiness
  • fast heartbeat
  • anxiety, irritability, or mood changes
  • hunger
  • weakness
  • feeling jittery
     

Talk with your healthcare provider about how to recognize and treat low blood sugar. Make sure that your family and other people around you know how to recognize and treat low blood sugar.

Some adults taking BYDUREON BCise can get a small, raised bump under their skin at the injection site. This is a normal body response to the tiny beads in BYDUREON BCise that slowly release medicine over time. The bump usually disappeared in an average of 4 weeks in BYDUREON clinical studies. The illustration below shows an average bump size.
 

Serious injection-site reactions, with or without bumps (nodules), have happened in some people who use BYDUREON. Some of these injection-site reactions have required surgery. Call your healthcare provider if you have any symptoms of an injection-site reaction, including severe pain, swelling, blisters, an open wound, or a dark scab.

Bump Icon

The illustration here shows an average bump size. In a BYDUREON clinical study, the bump went away on its own on average within 4 weeks. The image is based on healthcare providers' descriptions from BYDUREON clinical studies.

BYDUREON BCise may cause serious side effects, including:

  • POSSIBLE THYROID TUMORS, INCLUDING CANCER Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In animal studies, BYDUREON and medicines that work like it caused thyroid tumors, including thyroid cancer. It is not known if BYDUREON BCise will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
  • Do not use BYDUREON BCise if you or any of your family members have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Do not use BYDUREON BCise if you have a history of low blood platelet count from using exenatide medicines (drug-induced thrombocytopenia)
  • Do not use BYDUREON BCise if you have had an allergic reaction to exenatide or any of the other ingredients in BYDUREON BCise
  • Inflammation of the pancreas (pancreatitis) Stop using BYDUREON BCise and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back
  • Low blood sugar (hypoglycemia) Your risk for getting low blood sugar may be higher if you use BYDUREON BCise with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Tell your healthcare provider if you take other diabetes medicines. Talk to your healthcare provider about managing low blood sugar. Signs and symptoms of low blood sugar include dizziness or lightheadedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness, or feeling jittery
  • Kidney problems Tell your healthcare provider if you have or had kidney problems. In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse or kidney failure
  • Stomach problems Tell your healthcare provider if you have severe stomach problems, such as slowed emptying of your stomach (gastroparesis) or problems digesting food. Other medicines like BYDUREON BCise may cause severe stomach problems. It is not known if BYDUREON BCise causes or worsens stomach problems
  • Low blood platelet count BYDUREON BCise may cause the number of platelets in your blood to be reduced. When your platelet count is too low, your body cannot form blood clots. You could have serious bleeding that could lead to death. Stop using BYDUREON BCise and call your healthcare provider right away if you have unusual bleeding or bruising
  • Serious allergic reactions Stop using BYDUREON BCise and get medical help right away if you have any symptoms of a serious allergic reaction, including itching, rash, or difficulty breathing
  • Injection-site reactions Serious injection-site reactions, with or without bumps (nodules), have happened in some people who use BYDUREON BCise. Some of these injection-site reactions have required surgery. Call your healthcare provider if you have any symptoms of injection-site reactions, including severe pain, swelling, blisters, an open wound, or a dark scab
    Gallbladder problems have happened in some people who take BYDUREON or other medicines like it. Tell your healthcare provider right away if you get symptoms of gallbladder problems including pain in the right or middle upper stomach area, nausea and vomiting, fever, or your skin or the white part of your eyes turns yellow

The most common side effects with BYDUREON BCise may include a bump at the injection site and/or nausea. Nausea is most common when you first start using BYDUREON BCise, but decreases over time in most people as their body gets used to the medicine. These are not all the possible side effects of BYDUREON BCise. See the Important Safety Information for more information and talk to your healthcare provider if you have any side effects that bother you or do not go away. Also, talk to your healthcare provider if you have any changes in your medical condition or the medicines you take. You may report side effects related to AstraZeneca products by clicking here.

  • BYDUREON BCise is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus, and should be used along with diet and exercise
 
  • BYDUREON BCise is not recommended as the first choice of medicine for treating diabetes
 
  • BYDUREON BCise is not a substitute for insulin and is not for use for people with type 1 diabetes 
 
  • Do not use BYDUREON, BYDUREON BCise, BYETTA or other medicines containing exenatide together
 
  • It is not known if BYDUREON BCise can be used in people with a history of pancreatitis

Do not use BYDUREON BCise if:

  • You or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • You are allergic to exenatide or any of the ingredients in BYDUREON BCise. See the Medication Guide for a complete list of ingredients in BYDUREON BCise

Before using BYDUREON BCise, tell your healthcare provider about all of your medical conditions, including if you:

 

  • Have or have had problems with your pancreas or kidneys
     
  • Have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food
     
  • Are pregnant or plan to become pregnant. BYDUREON BCise may harm your unborn baby. Tell your healthcare provider if you become pregnant while using BYDUREON BCise. Talk to your healthcare provider about the best way to control your blood sugar if you plan to become pregnant or while you are pregnant
     
  • Are breastfeeding or plan to breastfeed. It is not known if BYDUREON BCise passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using BYDUREON BCise

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. BYDUREON BCise may affect the way some medicines work and some medicines may affect the way BYDUREON BCise works.

Before using BYDUREON BCise, talk to your healthcare provider about low blood sugar and how to manage it. Tell your healthcare provider if you are taking other medicines to treat diabetes including insulin or sulfonylureas.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

BYDUREON BCise has convenient once-weekly dosing and an extended-release delivery system. Each dose contains tiny beads that slowly dissolve to continuously release medicine into your body over time, helping your body release its own insulin, when needed, to help lower blood sugar.

After 10 weeks of continued once-weekly dosing, BYDUREON BCise keeps a consistent level of medicine in your body, working for you 7 days a week.

BYDUREON BCise is not insulin; it is a type 2 diabetes prescription medicine that is slowly released into your body over time, working to help your body release its own insulin when needed to help lower blood sugar.

BYDUREON BCise works with your body to:

  • Help the pancreas release insulin when blood sugar needs to be reduced
 
  • Prevent the release of a hormone that triggers the liver to make sugar when it’s not needed
 
  • Slow down how quickly the stomach empties, sending sugar into the bloodstream more slowly

BYDUREON BCise has been proven to help significantly lower A1C along with diet and exercise. Also, although not a weight-loss drug, BYDUREON BCise may help you lose some weight.

In one clinical study lasting 28 weeks, BYDUREON BCise lowered A1C by an average of 1.4% from an average starting A1C of 8.5% and lowered weight by an average of 3 lb from an average starting weight of 213 lb when used alone or with certain oral type 2 diabetes medicine(s). In a second clinical study, BYDUREON BCise lowered A1C by an average of 1.1% from an average starting A1C of 8.4% and lowered weight by an average of 3 lb after 28 weeks from an average starting weight of 196 lb when added to metformin. Your results may vary.

Because every person is different, it’s impossible to know how well BYDUREON BCise will work in any one person. However, BYDUREON BCise has been proven to help lower A1C in clinical studies along with diet and exercise.

In one clinical study lasting 28 weeks, BYDUREON BCise lowered A1C by an average of 1.4% from an average starting A1C of 8.5% and lowered weight by an average of 3 lb from an average starting weight of 213 lb when used alone or with certain oral type 2 diabetes medicines. In a second clinical study, BYDUREON BCise lowered A1C by an average of 1.1% from an average starting A1C of 8.4% and lowered weight by an average of 3 lb after 28 weeks from an average starting weight of 196 lb when added to metformin. Your results may vary.

BYDUREON BCise works gradually and continually. As you continue to take your weekly doses, the amount of medicine in your body gradually builds up over 10 weeks until it reaches an optimal level to work in your body. With continued once-weekly dosing, the extended-release delivery system of BYDUREON BCise keeps a consistent level of medicine in your body, ready to work when you need it to help lower your blood sugar.

Remember, you need to continue to take BYDUREON BCise exactly as your doctor or healthcare provider has prescribed it, along with continuing to follow the treatment plan they’ve recommended.

Take BYDUREON BCise just once each week with or without food, on the same day that best fits your busy schedule.

Remember, you need to continue to take BYDUREON BCise exactly as your doctor or healthcare provider has prescribed it, along with continuing to follow the treatment plan they’ve recommended.

You only need to use BYDUREON BCise once every 7 days. If you want to change your dosing day, you can. Your new dosing day must be at least 3 days after your last dose. Do not inject 2 doses of BYDUREON BCise less than 3 days apart.

For instance, if you wanted to change your dosing day from Friday to Sunday, you would:

  • Inject your dose of BYDUREON BCise on Friday
     
  • Wait 7 days until the following Friday. DO NOT inject BYDUREON BCise on that Friday
     
  • Inject your dose two days later on Sunday
     
  • Continue to inject your dose of BYDUREON BCise every Sunday after that
     

Once you’ve selected a dosing day that works for you, try to stay with it. It’s not a good idea to change your dosing day often.

 

If you miss an injection of BYDUREON BCise on your dosing day, give yourself an injection as soon as you can, unless your next dosing day is 1 or 2 days away. In that case, wait until your next regular dosing day. Then inject your next dose on your regular dosing day. Don’t inject 2 doses less than 3 days apart.

BYDUREON BCise is a different form of the same medicine, called exenatide extended-release, that is in BYDUREON, so do not use these medicines together.

If you are using BYDUREON or any other exenatide-based product and your healthcare provider prescribes BYDUREON BCise, you should follow your healthcare provider’s instructions about when to stop using BYDUREON and when to start using BYDUREON BCise.

BYDUREON BCise is a different form of the same medicine, called exenatide, that is in BYETTA, so do not use these medicines together.

If you are using BYETTA or any other exenatide-based product and your healthcare provider prescribes BYDUREON BCise, you should follow your healthcare provider’s instructions about when to stop using BYETTA and when to start using BYDUREON BCise.

When you first change from BYETTA to BYDUREON BCise, your blood sugar levels may be higher than usual and should get better in about 4 weeks.

For detailed instructions, see the full Instructions for Use that comes with your BYDUREON BCise prescription.
 

  • Your healthcare provider should teach you how to use BYDUREON BCise before you use it for the first time. If you have any questions or do not understand the instructions, talk with your healthcare provider or pharmacist

  • Use BYDUREON BCise exactly as your healthcare provider tells you to

  • You can take BYDUREON BCise with or without food
     

You can watch a short instructional video demonstrating how to use the BYDUREON BCise device here.

If you have questions about how to use BYDUREON BCise, you can speak to a nurse by calling 1-844-MY-BCISE (1-844-692-2473)(8 AM to 8 PM ET, Monday through Friday and 10 AM to 6 PM, Saturday and Sunday). You also can speak directly to a nurse through video chat who can demonstrate the injection technique and even watch as you perform your own injection. Click here for more details.*

 

*AstraZeneca cannot provide medical advice and can only provide information about AstraZeneca medication. Decisions regarding your health and treatment of your condition should be made with your own healthcare provider.

BYDUREON BCise should be stored flat in the refrigerator between 36°F and 46°F (2°C to 8°C).
 

BYDUREON BCise can be kept at room temperature not exceeding 86°F (30°C) for up to 4 weeks, so you can take your weekly dose where it is most convenient for you.

 

For detailed storage instructions, see the Instructions for Use that comes with your BYDUREON BCise prescription.

Devices stored vertically (with the needle up or down) are more difficult to mix. The medicine can still be fully mixed, but it will need to be shaken longer than the recommended 15 seconds.

The device can be kept at room temperature not exceeding 86°F (30°C) for up to 4 weeks, so you can take your weekly dose where it is most convenient for you.
 

For detailed storage instructions, see the Instructions for Use that comes with your BYDUREON BCise prescription.

The needle is attached to the device and covered by the orange cap. When you unscrew the orange cap when taking BYDUREON BCise, a green shield pops up from the device to keep the needle covered until you inject.
 

For detailed storage instructions, see the Instructions for Use that comes with your BYDUREON BCise prescription.

After shaking the device, look through both sides of the window. You should not see any white medicine along the bottom, top, or sides. If you see white medicine, it is unmixed. To mix, shake the device hard with the orange cap pointing toward the ceiling until the white medicine is no longer on the bottom, top, or sides. The medicine should look even throughout. The medicine must be mixed well and look cloudy to ensure you get the full dose.

Holding the device with the orange cap straight up helps prevent the medicine from leakage. It is normal to see a few drops of medicine inside the orange cap after you unscrew it.

If you do not inject your medicine right away after mixing, the medicine may separate, and you will not get your full dose. You can re-mix your medicine if your device is in the locked position. However, after you unlock it, you must complete the preparation steps right away and inject to get the full dose. You cannot save it for later use.

To be sure you get your full dose, press and hold the device against your skin. You will feel the needle go into your skin. Hold the needle against your skin for 15 seconds. This will allow enough time for all the medicine to go from the autoinjector to under your skin. After removing the needle, look for the orange rod in the window as a way to tell that the dose has been given. If the orange rod does not appear, contact Customer Service at 1-877-700-7365.

Do not throw away (dispose of) the device in your household trash. If you do not have an FDA-cleared sharps disposal container, you may use a household container that is:
 

  • Made of heavy-duty plastic
  • Can be closed with a tight-fitting, puncture-resistant lid, that won’t let sharps come out
  • Upright and stable during use
  • Leak-resistant
  • Properly labeled to warn of hazardous waste inside the container
     

When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles and injection devices.

Review the Instructions for Use Step 3 to make sure you are following the right instructions, then contact Customer Service at 1-877-700-7365 for help as needed. Do not try to unlock with excessive force or tools.

Review the Instructions for Use Step 3 to confirm the order of operations, also confirm that the knob is fully in the unlocked position, then call the Customer Service at 1-877-700-7365 for help as needed. Do not use tools or try to force the cap off.

No, the device is not reusable. After dosing once, place the entire device in an appropriate sharps container. Use a new device for each dose.

BYDUREON BCise Savings Card
BYDUREON BCise Savings Card

Sign up for savings and support comes with it

*Most commercially insured patients are eligible for a $0 co-pay for as long as your doctor prescribes BYDUREON BCise. See eligibility requirementsRestrictions apply. Not available for government-insured patients.

Video still of Kristen, a Registered Nurse from the BYDUREON BCise Support Team
Video still of Kristen, a Registered Nurse from the BYDUREON BCise Support Team

Nurse injection help when you need it

Have questions about how to use BYDUREON BCise? Or injecting for the first time? Feel free to talk or video chat with one of our BYDUREON BCise nurses for the support you need.

You can speak to a nurse by calling

1-844-MY-BCISE (1-844-692-2473)

8 AM – 8 PM ET, Monday – Friday

and 10 AM – 6 PM, Saturday and Sunday*

*AstraZeneca cannot provide medical advice and can only provide information about AstraZeneca medications. Decisions regarding your health and treatment of your condition should be made with your own healthcare provider.

IMPORTANT SAFETY INFORMATION

BYDUREON BCise may cause serious side effects, including:

  • POSSIBLE THYROID TUMORS, INCLUDING CANCER Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In animal studies, BYDUREON and medicines that work like it caused thyroid tumors, including thyroid cancer. It is not known if BYDUREON BCise will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people
  • Do not use BYDUREON BCise if you or any of your family members have ever had MTC or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Do not use BYDUREON BCise if you have a history of low blood platelet count from using exenatide medicines (drug-induced thrombocytopenia)
  • Do not use BYDUREON BCise if you have had an allergic reaction to exenatide or any of the other ingredients in BYDUREON BCise
  • Inflammation of the pancreas (pancreatitis) Stop using BYDUREON BCise and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back
  • Low blood sugar (hypoglycemia) Your risk for getting low blood sugar may be higher if you use BYDUREON BCise with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Tell your healthcare provider if you take other diabetes medicines. Talk to your healthcare provider about managing low blood sugar. Signs and symptoms of low blood sugar include dizziness or lightheadedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness, or feeling jittery
  • Kidney problems Tell your healthcare provider if you have or had kidney problems. In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse or kidney failure
  • Stomach problems Tell your healthcare provider if you have severe stomach problems, such as slowed emptying of your stomach (gastroparesis) or problems digesting food. Other medicines like BYDUREON BCise may cause severe stomach problems. It is not known if BYDUREON BCise causes or worsens stomach problems
  • Low blood platelet count BYDUREON BCise may cause the number of platelets in your blood to be reduced. When your platelet count is too low, your body cannot form blood clots. You could have serious bleeding that could lead to death. Stop using BYDUREON BCise and call your healthcare provider right away if you have unusual bleeding or bruising
  • Serious allergic reactions Stop using BYDUREON BCise and get medical help right away if you have any symptoms of a serious allergic reaction, including itching, rash, or difficulty breathing
  • Injection-site reactions Serious injection-site reactions, with or without bumps (nodules), have happened in some people who use BYDUREON BCise. Some of these injection-site reactions have required surgery. Call your healthcare provider if you have any symptoms of injection-site reactions, including severe pain, swelling, blisters, an open wound, or a dark scab
  • Gallbladder problems have happened in some people who take BYDUREON or other medicines like it. Tell your healthcare provider right away if you get symptoms of gallbladder problems including pain in the right or middle upper stomach area, nausea and vomiting, fever, or your skin or the white part of your eyes turns yellow

The most common side effects with BYDUREON BCise may include a bump at the injection site and/or nausea. Nausea is most common when you first start using BYDUREON BCise, but decreases over time in most people as their body gets used to the medicine.

Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements, as taking them with BYDUREON BCise may affect how each medicine works.

Before using BYDUREON BCise, tell your healthcare provider if you are pregnant, nursing, or plan to become pregnant or nurse. BYDUREON BCise may harm your unborn baby.

APPROVED USES

  • BYDUREON BCise is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus, and should be used along with diet and exercise
  • BYDUREON BCise is not recommended as the first choice of medicine for treating diabetes
  • BYDUREON BCise is not for people with type 1 diabetes
  • Do not use BYDUREON, BYDUREON BCise, BYETTA or other medicines containing exenatide together
  • It is not known if BYDUREON BCise can be used in people with a history of pancreatitis 

Please click here for Medication Guide, and click here for Full Prescribing Information for BYDUREON BCise.

You may report side effects related to AstraZeneca products by clicking here.

Approved Uses and Important Safety Information

POSSIBLE RISK OF THYROID TUMORS INCLUDING THYROID CANCER

Read More